Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311399092> ?p ?o ?g. }
- W4311399092 endingPage "2796" @default.
- W4311399092 startingPage "2796" @default.
- W4311399092 abstract "Here, we describe the synthesis of a novel type of rare-earth-doped nanoparticles (NPs) for multimodal imaging, by combining the rare-earth elements Ce, Gd and Nd in a crystalline host lattice consisting of CaF2 (CaF2: Ce, Gd, Nd). CaF2: Ce, Gd, Nd NPs are small (15-20 nm), of uniform shape and size distribution, and show good biocompatibility and low immunogenicity in vitro. In addition, CaF2: Ce, Gd, Nd NPs possess excellent optical properties. CaF2: Ce, Gd, Nd NPs produce downconversion emissions in the second near-infrared window (NIR-II, 1000-1700 nm) under 808 nm excitation, with a strong emission peak at 1056 nm. Excitation in the first near- infrared window (NIR-I, 700-900 nm) has the advantage of deeper tissue penetration power and reduced autofluorescence, compared to visible light. Thus, CaF2: Ce, Gd, Nd NPs are ideally suited for in vivo fluorescence imaging. In addition, the presence of Gd3+ makes the NPs intrinsically monitorable by magnetic resonance imaging (MRI). Moreover, next to fluorescence and MR imaging, our results show that CaF2: Ce, Gd, Nd NPs can be used as imaging probes for photoacoustic imaging (PAI) in vitro. Therefore, due to their biocompatibility and suitability as multimodal imaging probes, CaF2: Ce, Gd, Nd NPs exhibit great potential as a traceable imaging agent in biomedical applications." @default.
- W4311399092 created "2022-12-26" @default.
- W4311399092 creator A5001088841 @default.
- W4311399092 creator A5019724319 @default.
- W4311399092 creator A5045264039 @default.
- W4311399092 creator A5050568639 @default.
- W4311399092 creator A5051804103 @default.
- W4311399092 creator A5068102754 @default.
- W4311399092 creator A5073704425 @default.
- W4311399092 creator A5080460002 @default.
- W4311399092 creator A5083180217 @default.
- W4311399092 date "2022-12-14" @default.
- W4311399092 modified "2023-09-27" @default.
- W4311399092 title "Rare-Earth-Metal (Nd3+, Ce3+ and Gd3+)-Doped CaF2: Nanoparticles for Multimodal Imaging in Biomedical Applications" @default.
- W4311399092 cites W1545968958 @default.
- W4311399092 cites W1903778810 @default.
- W4311399092 cites W1944560526 @default.
- W4311399092 cites W1967678184 @default.
- W4311399092 cites W1970547401 @default.
- W4311399092 cites W1972557751 @default.
- W4311399092 cites W1977016792 @default.
- W4311399092 cites W1982271583 @default.
- W4311399092 cites W1983484918 @default.
- W4311399092 cites W1992680356 @default.
- W4311399092 cites W1993522558 @default.
- W4311399092 cites W1993627086 @default.
- W4311399092 cites W1995492424 @default.
- W4311399092 cites W2007303612 @default.
- W4311399092 cites W2012492137 @default.
- W4311399092 cites W2020697271 @default.
- W4311399092 cites W2022429751 @default.
- W4311399092 cites W2025908197 @default.
- W4311399092 cites W2032861454 @default.
- W4311399092 cites W2043680485 @default.
- W4311399092 cites W2046527344 @default.
- W4311399092 cites W2064529000 @default.
- W4311399092 cites W2073240930 @default.
- W4311399092 cites W2087252393 @default.
- W4311399092 cites W2094769494 @default.
- W4311399092 cites W2095897277 @default.
- W4311399092 cites W2099039308 @default.
- W4311399092 cites W2119968485 @default.
- W4311399092 cites W2127632601 @default.
- W4311399092 cites W2133478969 @default.
- W4311399092 cites W2151859760 @default.
- W4311399092 cites W2152681353 @default.
- W4311399092 cites W2158985428 @default.
- W4311399092 cites W2162662999 @default.
- W4311399092 cites W2328596254 @default.
- W4311399092 cites W2517490161 @default.
- W4311399092 cites W2536598586 @default.
- W4311399092 cites W2553686676 @default.
- W4311399092 cites W2600987783 @default.
- W4311399092 cites W2601389856 @default.
- W4311399092 cites W2747776602 @default.
- W4311399092 cites W2782688470 @default.
- W4311399092 cites W2784570901 @default.
- W4311399092 cites W2800461297 @default.
- W4311399092 cites W2884520657 @default.
- W4311399092 cites W2885804526 @default.
- W4311399092 cites W2899721009 @default.
- W4311399092 cites W2903971245 @default.
- W4311399092 cites W2913536482 @default.
- W4311399092 cites W2920977620 @default.
- W4311399092 cites W2956004678 @default.
- W4311399092 cites W2995160929 @default.
- W4311399092 cites W3000923888 @default.
- W4311399092 cites W3017370139 @default.
- W4311399092 cites W3036157440 @default.
- W4311399092 cites W3044460210 @default.
- W4311399092 cites W3082476274 @default.
- W4311399092 cites W3092591754 @default.
- W4311399092 cites W3109135541 @default.
- W4311399092 cites W3121222020 @default.
- W4311399092 cites W3123536892 @default.
- W4311399092 cites W3124979445 @default.
- W4311399092 cites W4206921918 @default.
- W4311399092 cites W4223527645 @default.
- W4311399092 cites W766260328 @default.
- W4311399092 cites W80245502 @default.
- W4311399092 doi "https://doi.org/10.3390/pharmaceutics14122796" @default.
- W4311399092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36559291" @default.
- W4311399092 hasPublicationYear "2022" @default.
- W4311399092 type Work @default.
- W4311399092 citedByCount "1" @default.
- W4311399092 countsByYear W43113990922023 @default.
- W4311399092 crossrefType "journal-article" @default.
- W4311399092 hasAuthorship W4311399092A5001088841 @default.
- W4311399092 hasAuthorship W4311399092A5019724319 @default.
- W4311399092 hasAuthorship W4311399092A5045264039 @default.
- W4311399092 hasAuthorship W4311399092A5050568639 @default.
- W4311399092 hasAuthorship W4311399092A5051804103 @default.
- W4311399092 hasAuthorship W4311399092A5068102754 @default.
- W4311399092 hasAuthorship W4311399092A5073704425 @default.
- W4311399092 hasAuthorship W4311399092A5080460002 @default.
- W4311399092 hasAuthorship W4311399092A5083180217 @default.
- W4311399092 hasBestOaLocation W43113990921 @default.
- W4311399092 hasConcept C120665830 @default.